Stock Events

Stock Events

CervoMed 

€3.38
0
-€0.02-0.59% Today

Statistics

Day High
3.42
Day Low
3.36
52W High
10.1
52W Low
3.08
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DP8.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap111.22B
Medtronic is a major player in the medical devices sector, directly competing with CervoMed in multiple healthcare technology markets.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific competes with CervoMed in developing advanced medical devices for various therapeutic areas.
Stryker
SYK
Mkt Cap126.97B
Stryker operates in the same sectors as CervoMed, particularly in orthopedics and neurotechnology, making them direct competitors.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a broad range of medical devices and diagnostics, overlapping with CervoMed's product lines.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical provides robotic-assisted surgical systems, competing with CervoMed's innovations in medical technology.
Zimmer Biomet
ZBH
Mkt Cap18.01B
Zimmer Biomet competes in the musculoskeletal healthcare sector, directly challenging CervoMed's offerings in orthopedic devices.
Edwards Lifesciences
EW
Mkt Cap47.07B
Edwards Lifesciences specializes in heart valve therapy and critical care, areas where CervoMed also operates.
Baxter International
BAX
Mkt Cap8.61B
Baxter International competes with CervoMed in the development and manufacturing of medical products, including hospital and renal care devices.
Resmed
RMD
Mkt Cap32.71B
ResMed is known for its sleep and respiratory care devices, competing with CervoMed's products in similar therapeutic areas.

About

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Show more...
CEO
Dr. John J. Alam M.D.
Employees
15
Country
DE
ISIN
US15713L1098

Listings

STU
DE
DP8.STU
F
DE
DP8.F
XNAS
US
CRVO
BOATS
BOATS
CRVO.BOATS

0 Comments

Share your thoughts

FAQ

What is CervoMed stock price today?▼
The current price of DP8.STU is €3.38 EUR — it has decreased by -0.59% in the past 24 hours. Watch CervoMed stock price performance more closely on the chart.
What is CervoMed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CervoMed stocks are traded under the ticker DP8.STU.
Is CervoMed stock price growing?▼
DP8.STU stock has fallen by -3.43% compared to the previous week, the month change is a -17.56% fall, over the last year CervoMed has showed a -56.94% decrease.
How many employees does CervoMed have?▼
As of April 10, 2026, the company has 15 employees.
When did CervoMed complete a stock split?▼
CervoMed has not had any recent stock splits.
Where is CervoMed headquartered?▼
CervoMed is headquartered in Boston, DE.